Floatz logo

Therapeutic Asset Ratings

261 results matching 1 filter

128,359 assets · 8,667 sponsors · 3,127 indications
Methodology v0.2
AssetSponsorPhaseRating
DEXAMETHASONE
precursor lymphoblastic lymphoma/leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (63)
Fludarabine
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (63)
Fludarabine
B Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2/3B (63)
Pcc
hemophilia
Institute of Hematology & Blood Diseases Hospital, ChinaP4B (62)
cc-5013
mantle cell lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (62)
Siltuximab
plasma cell myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (62)
Fludarabine
BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (62)
Siltuximab
cytokine release syndrome
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (61)
Cyclophosphamide
RUNX1-RUNX1T1 Fusion Protein Expression
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (60)
Cytosin-Arabinosid
RUNX1-RUNX1T1 Fusion Protein Expression
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (60)
Daunorubicin
RUNX1-RUNX1T1 Fusion Protein Expression
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (60)
Idarubicine
RUNX1-RUNX1T1 Fusion Protein Expression
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (60)
Tafasitamab
follicular lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (60)
Cyclophosphamide
precursor lymphoblastic lymphoma/leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
DARATUMUMAB
adult acute lymphoblastic leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Fludarabine
T-lymphoblastic lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Obinutuzumab
aggressive B-cell non-Hodgkin lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Venetoclax
FLT3 Gene Mutation
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Venetoclax
mixed phenotype acute leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Vinorelbine
Diffuse Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Bbm-H901
hemophilia B
Institute of Hematology & Blood Diseases Hospital, ChinaP2/3B (60)
CIS-DIAMMINEDICHLOROPLATINUM II
relapsed/refractory diffuse large B-cell lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2/3B (60)
Blinatumomab
mixed phenotype acute leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (59)
Flumatinib
acute leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP4B (58)
cc-5013
Acute Lymphoblastic Leukemia, Adult
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (58)
Showing 51 to 75 of 261 assets
PreviousPage 3 of 11Next